Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Se-Woong Oh"'
Autor:
Sung Sook Lee, Young Sung Lee, Min Hee Hong, Mi Ran Yun, Kyoung Ho Pyo, Byoung Chul Cho, Koh Jong Sung, Hye Ryun Kim, Han Na Kang, So-Young Kim, Ho Juhn Song, Dong-Kyun Kim, Se Woong Oh, Soongyu Choi, Chae Won Park, Jiyeon Yun, Seok Young Kim
Publikováno v:
Clinical Cancer Research. 25:2575-2587
Purpose: Given that osimertinib is the only approved third-generation EGFR-TKI against EGFR activating and resistant T790M mutated non–small cell lung cancer (NSCLC), additional mutant-selective inhibitors with a higher efficacy, especially for bra
Autor:
Dae Won Kim, Sung Byungje, Yangsoon Lee, KyeongBae Kim, Su Jin Ahn, Wonjun Son, Yeom Donghoon, J.K. Lee, Chung Hyejin, Weon-Kyoo You, Ju Young Park, Eun Jung Kim, Young Bong Park, Song Daehae, Mikyeong Ju, Eom Jaehyun, Ahn Jinhyung, Jaeho Jung, Moo Young Song, Jung Uijung, Jong Gyun Kim, Jun Hwan Kim, Eunjung Lee, Park Kyeongsu, Se-Woong Oh, Min Hyeok Jee, Kyoung Kyu Ahn, Byung Hyun Choi
Publikováno v:
Cancer Research. 80:6524-6524
4-1BB (TNFSF9, CD137) is a member of the tumor necrosis factor receptor superfamily that functions as a potent costimulator to immune cells, especially T-cell. Although current 4-1BB-targeted strong agonistic antibody exhibit a considerable anti-tumo
Autor:
Jong Sung Koh, So-Young Kim, Young Sung Lee, Seok-Young Kim, Jiyeon Yun, Kyoung Ho Pyo, Byoung Chul Cho, Han Na Kang, Min Hee Hong, Mi Ran Yun, Soongyu Choi, Chae Won Park, Ho-Juhn Song, Se-Woong Oh
Publikováno v:
Cancer Research. 78:4790-4790
EGFR mutated lung cancer shows approximately 10-15% of non-small cell lung cancer (NSCLC). Although the best therapeutic EGFR tyrosine kinase inhibitors (TKIs) targeting mutant EGFR, such as gefitinib and erlotinib, are used in the first line treatme
Autor:
Isabelle Briaud, Ji-Eun Jung, Kathy Emami, Se-Woong Oh, Kyung Yun Jung, Kwan-Hoo Lee, Hee Kyung Jung, Jong Heun Lee, Younghee Pyon, Jin Keon Pai, Fnu Tenzin, Jae Uk Chung, Joo Young Cha, Donghee Lee
Publikováno v:
Blood. 116:3038-3038
Abstract 3038 Multiple myeloma (MM), one of the most incurable hematological malignancies in adults, is a disorder of plasma cells characterized by accumulation of clonal proliferation of malignant plasma cells in the bone marrow (BM). Overexpression